Goodman Advisory Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Goodman Advisory Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6	Closed	-$766	–	179
2026 Q1	$766	Hold	6	–	–	﹤0.01%	178
2025 Q4	$732	Hold	6	–	–	﹤0.01%	180
2025 Q3	$601	Hold	6	–	–	﹤0.01%	180
2025 Q2	$498	Hold	6	–	–	﹤0.01%	143
2025 Q1	$487	Buy	+6	New	+$536	﹤0.01%	177
2024 Q4	–	Sell	-6	Closed	-$593	–	189
2024 Q3	$593	Hold	6	–	–	﹤0.01%	191
2024 Q2	$556	Sell	6 -7	-54%	-$628	﹤0.01%	172
2024 Q1	$1.23K	Hold	13	–	–	﹤0.01%	160
2023 Q4	$1.16K	Hold	13	–	–	﹤0.01%	143
2023 Q3	$949	Hold	13	–	–	﹤0.01%	147
2023 Q2	$1.08K	Hold	13	–	–	﹤0.01%	145
2023 Q1	$991	Hold	13	–	–	﹤0.01%	148
2022 Q4	$1K	Hold	13	–	–	﹤0.01%	140
2022 Q3	$1K	Hold	13	–	–	﹤0.01%	157
2022 Q2	$1K	Buy	+13	New	+$976	﹤0.01%	169

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Goodman Advisory Group's XBI Position: Q2 2026 in Review

Goodman Advisory Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 6 shares — an estimated $766 sold.

Goodman Advisory Group first reported a position in XBI in Q2 2022 and held it in 15 quarters. The position peaked at $1.23K in Q1 2024. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Goodman Advisory Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
Goodman Advisory Group sold 6 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $766.
Goodman Advisory Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 15 quarters.
Goodman Advisory Group's State Street SPDR S&P Biotech ETF position peaked at $1.23K in Q1 2024.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Goodman Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.